Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Fedanov A"'
Autor:
Gianna M. Branella, Jasmine Y. Lee, Jennifer Okalova, Kiran K. Parwani, Jordan S. Alexander, Raquel F. Arthuzo, Andrew Fedanov, Bing Yu, David McCarty, Harrison C. Brown, Shanmuganathan Chandrakasan, Brian G. Petrich, Christopher B. Doering, H. Trent Spencer
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
The application of immunotherapies such as chimeric antigen receptor (CAR) T therapy or bi-specific T cell engager (BiTE) therapy to manage myeloid malignancies has proven more challenging than for B-cell malignancies. This is attributed to a shortag
Externí odkaz:
https://doaj.org/article/075381e09c6f4fada8ebe38297960f22
Autor:
Lee, Jasmine Y., Jonus, Hunter C., Sadanand, Arhanti, Branella, Gianna M., Maximov, Victor, Suttapitugsakul, Suttipong, Schniederjan, Matthew J., Shim, Jenny, Ho, Andrew, Parwani, Kiran K., Fedanov, Andrew, Pilgrim, Adeiye A., Silva, Jordan A., Schnepp, Robert W., Doering, Christopher B., Wu, Ronghu, Spencer, H. Trent, Goldsmith, Kelly C.
Publikováno v:
In Cell Reports Medicine 20 June 2023 4(6)
Autor:
Funk, Christopher Ronald *, Wang, Shuhua *, Chen, Kevin Z., Waller, Alexandra *, Sharma, Aditi, Edgar, Claudia L., Gupta, Vikas A., Chandrakasan, Shanmuganathan, Zoine, Jaquelyn T., Fedanov, Andrew, Raikar, Sunil S., Koff, Jean L., Flowers, Christopher R., Coma, Silvia, Pachter, Jonathan A., Ravindranathan, Sruthi, Spencer, H. Trent, Shanmugam, Mala, Waller, Edmund K. *
Publikováno v:
In Blood 27 January 2022 139(4):523-537
Autor:
Knight, Kristopher A., Coyle, Christopher W., Radford, Caelan E., Parker, Ernest T., Fedanov, Andrew, Shields, Jordan M., Szlam, Fania, Purchel, Anatolii, Chen, Michelle, Denning, Gabriela, Sniecinski, Roman M., Lollar, Pete, Spencer, H. Trent, Gaucher, Eric A., Doering, Christopher B. *
Publikováno v:
In Blood Advances 14 September 2021 5(17):3333-3343
Autor:
Smith, Ian W., d'Aquino, Anne E., Coyle, Christopher W., Fedanov, Andrew, Parker, Ernest T., Denning, Gabriela, Spencer, Harold Trent, Lollar, Pete, Doering, Christopher B., Spiegel, Paul Clint, Jr. *
Publikováno v:
In Journal of Thrombosis and Haemostasis January 2020 18(1):57-69
Autor:
Lauren C. Fleischer, Scott A. Becker, Rebecca E. Ryan, Andrew Fedanov, Christopher B. Doering, H. Trent Spencer
Publikováno v:
Molecular Therapy: Oncolytics, Vol 18, Iss , Pp 149-160 (2020)
Chimeric antigen receptor (CAR)-modified T cells have demonstrated efficacy against B cell leukemias/lymphomas. However, redirecting CAR T cells to malignant T cells is more challenging due to product-specific cis- and trans-activation causing fratri
Externí odkaz:
https://doaj.org/article/57c3a61041d34dbe85e0bb0f4d7cdf17
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Branella, Gianna M., Lee, Jasmine Y., Okalova, Jennifer, Parwani, Kiran K., Alexander, Jordan S., Arthuzo, Raquel F., Fedanov, Andrew, Bing Yu, McCarty, David, Brown, Harrison C., Chandrakasan, Shanmuganathan, Petrich, Brian G., Doering, Christopher B., Spencer, H. Trent
Publikováno v:
Frontiers in Immunology; 2023, p1-18, 18p
Autor:
Sunil S. Raikar, Lauren C. Fleischer, Robert Moot, Andrew Fedanov, Na Yoon Paik, Kristopher A. Knight, Christopher B. Doering, H. Trent Spencer
Publikováno v:
OncoImmunology, Vol 7, Iss 3 (2018)
Relapsed T-cell malignancies have poor outcomes when treated with chemotherapy, but survival after allogeneic bone marrow transplantation (BMT) approaches 50%. A limitation to BMT is the difficulty of achieving remission prior to transplant. Chimeric
Externí odkaz:
https://doaj.org/article/595175915e694c6f9cbda7b8ad257be9